Eli Lilly and Company, D-Wave Quantum, Novo Nordisk A/S, Doximity, and AbbVie are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies engaged in the research, development, manufacturing and marketing of drugs and medical therapies. As part of the broader healthcare sector, they offer investors exposure to the potential growth of new treatments while carrying risks tied to regulatory approval processes, clinical-trial outcomes and patent expirations. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY traded up $25.49 during mid-day trading on Friday, reaching $757.28. 3,042,297 shares of the stock traded hands, compared to its average volume of 3,580,251. The company has a market cap of $717.70 billion, a price-to-earnings ratio of 64.67, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a 1 year low of $677.09 and a 1 year high of $972.53. The firm has a fifty day moving average price of $799.17 and a 200 day moving average price of $807.15. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00.
Read Our Latest Research Report on LLY
D-Wave Quantum (QBTS)
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.
QBTS traded up $1.32 on Friday, reaching $12.35. The company had a trading volume of 88,729,969 shares, compared to its average volume of 37,956,120. D-Wave Quantum has a 52-week low of $0.75 and a 52-week high of $12.62. The company has a market cap of $3.60 billion, a price-to-earnings ratio of -29.22 and a beta of 0.90. The business has a 50 day simple moving average of $7.86 and a 200 day simple moving average of $6.05.
Read Our Latest Research Report on QBTS
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Novo Nordisk A/S stock traded down $2.04 during mid-day trading on Friday, hitting $64.11. The company's stock had a trading volume of 14,666,603 shares, compared to its average volume of 6,531,421. The business has a 50 day moving average price of $67.59 and a 200-day moving average price of $84.91. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15. The stock has a market cap of $287.69 billion, a price-to-earnings ratio of 19.48, a price-to-earnings-growth ratio of 0.90 and a beta of 0.65. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.74 and a quick ratio of 0.55.
Read Our Latest Research Report on NVO
Doximity (DOCS)
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
DOCS stock traded down $5.95 during trading on Friday, hitting $52.50. 14,036,177 shares of the company traded hands, compared to its average volume of 2,103,078. The company has a 50-day moving average of $57.58 and a 200-day moving average of $57.65. Doximity has a 1 year low of $23.52 and a 1 year high of $85.21. The firm has a market capitalization of $9.80 billion, a PE ratio of 52.26, a P/E/G ratio of 4.10 and a beta of 1.41.
Read Our Latest Research Report on DOCS
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
NYSE ABBV traded up $1.09 during trading hours on Friday, reaching $182.77. 3,395,389 shares of the company's stock traded hands, compared to its average volume of 7,376,625. The firm has a market cap of $323.31 billion, a PE ratio of 76.13, a PEG ratio of 1.62 and a beta of 0.56. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. AbbVie has a 52-week low of $153.58 and a 52-week high of $218.66. The firm has a 50-day simple moving average of $191.89 and a 200 day simple moving average of $187.11.
Read Our Latest Research Report on ABBV
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
